Trueblue
TBI
183 hedge funds and large institutions have $941M invested in Trueblue in 2022 Q1 according to their latest regulatory filings, with 22 funds opening new positions, 52 increasing their positions, 74 reducing their positions, and 14 closing their positions.
57% more first-time investments, than exits
New positions opened: 22 | Existing positions closed: 14
4% more funds holding
Funds holding: 176 → 183 (+7)
2% more capital invested
Capital invested by funds: $927M → $941M (+$14M)
0.2% more ownership
Funds ownership: 94.48% → 94.68% (+0.2%)
30% less repeat investments, than reductions
Existing positions increased: 52 | Existing positions reduced: 74
Top Buyers
Top Sellers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$13.6M |
| 2 |
Acadian Asset Management
Boston,
Massachusetts
|
-$5.14M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
-$4.94M |
| 4 |
RA
Royce & Associates
New York
|
-$3.26M |
| 5 |
State of New Jersey Common Pension Fund D
Trenton,
New Jersey
|
-$2.95M |
TBI Hedge Fund Activity: Q1 2022 in Review
183 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Trueblue (TBI) for Q1 2022, worth a combined $941M — up 1.5% from $927M a quarter earlier.
Buyers outnumbered sellers: 22 funds opened new TBI positions and 14 closed out — a net gain of 8 holders — while 52 added to existing stakes and 74 trimmed.
The largest buyer was Hotchkis & Wiley Capital Management, adding an estimated $5.94M. The largest seller was Fidelity Investments, cutting an estimated $13.6M.
- 183 institutional investors held Trueblue (TBI) as of Q1 2022, up from 176 in Q4 2021.
- Funds reported $941M of Trueblue stock for Q1 2022, up 1.5% quarter-over-quarter.
- 22 funds opened new Trueblue positions in Q1 2022 and 14 closed out, a net change of +8 holders.
- The largest Trueblue buyer in Q1 2022 was Hotchkis & Wiley Capital Management, an estimated $5.94M added.
- The largest Trueblue seller in Q1 2022 was Fidelity Investments, an estimated $13.6M sold.
Based on aggregated 13F filings for Q1 2022.